Hemex Health Stock
Develops malaria and sickle cell diagnostic devices.
Sign up today and learn more about Hemex Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Hemex Health Stock
They seek out and work with brilliant inventors to deliver revolutionary solutions to global health problems. Our innovative products are designed to help millions of people across all markets, especially in underserved areas.
Funding History
| December 2016 | $1.5M |
|---|---|
| June 2017 | $3.0M |
| August 2017 | $25K |
| November 2017 | $600K |
| December 2017 | $1.7M |
Management
CIO
Peter Galen
CEO
Patti White
Vice President Engineering
Daren Bledsoe
Press
whatech - Dec, 25 2023
Sickle Cell Anemia Testing & Screening Market to reach USD 383 million by 2030 according to a new research ...globenewswire - Dec, 25 2023
Global Sickle Cell Anemia Testing & Screening Market ...news-medical - Mar, 30 2023
Hemex Health awarded $3 million grant to advance commercialization of Gazelle Hb Variant Test for the U.S. markettechlinkcenter - Jul, 24 2019
Hemex Health developing malaria detector with Navy researchers in PeruEquityZen Recognized As:
